FDA Drug recall D-1153-2018
Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd
- FDA Drug
- Class II
- terminated
- Published 2018-09-05
On 2018-09-05 the FDA classified a Class II recall of Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd by Pharmcore, citing lack of assurance of sterility.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1153-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-08-02 |
| Published | 2018-09-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Pharmcore |
| Distribution | US |
Product
Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Reason
Lack of assurance of sterility.
Identifiers
| code_info | Lot: IPA3-17 Exp. 07/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1153-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.